Oncology Practice · Oncology

Oncology Prior Authorization for Chemotherapy and Imaging

Illustrative Revenue Cycle Automation Scenario. This scenario demonstrates how a healthcare organization could apply revenue-cycle automation. It is not presented as an actual customer result.

The Challenge

An oncology practice faced treatment delays due to prior authorization requirements for chemotherapy regimens, PET/CT imaging, and supportive care drugs. Each regimen required a separate PA with specific clinical documentation. Delays in authorization directly impacted patient care — chemotherapy could not begin until authorization was confirmed.

The Approach

1

Sarva configured oncology-specific PA requirements for common chemotherapy regimens, imaging studies, and supportive care drugs.

2

Clinical documentation was auto-retrieved from the EHR and packaged with PA submissions.

3

Status tracking was automated with escalations for PAs pending beyond 24 hours — critical for oncology where treatment timing matters.

4

Regimen-specific PA templates were created for the most common treatment protocols.

Illustrative Outcomes

PA turnaround
Illustrative reduction from 5 days to 48 hours
Treatment delays
Illustrative significant reduction
Staff time on PA
Illustrative 70% reduction

Outcomes are illustrative and do not represent actual customer results.

Key Lessons

  • Oncology PA automation must prioritize speed — treatment delays directly impact patient outcomes.
  • Regimen-specific templates dramatically reduce PA preparation time.
  • 24-hour escalation thresholds are critical for oncology, tighter than other specialties.

See how this approach could work for your organization.

Book an RCM Automation Demo

Frequently Asked Questions

No. This is an illustrative scenario. The metrics shown are illustrative, not actual customer results.

Want similar results for your practice?

Book a personalized demo and see how Sarva can apply this approach to your organization.